<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7238951\results\search\testTrace\results.xml">
  <result pre="however, is appreciated. Identifying persons with hepatitis C virus (HCV)" exact="infection" post="has become an urgent public health challenge because of"/>
  <result pre="advent of curative therapies (1). Since 2012, CDC has recommended" exact="testing" post="of all persons born during 1945â€&quot;1965 (baby boomers) for"/>
  <result pre="born during 1945â€&quot;1965 (baby boomers) for identification of chronic HCV" exact="infection" post="(1); urban emergency departments (EDs) are well positioned venues"/>
  <result pre="emergency departments (EDs) are well positioned venues for detecting HCV" exact="infection" post="among these persons. The United States has witnessed an"/>
  <result pre="concern about increases in human immunodeficiency virus (HIV) and HCV" exact="infection" post="within communities disproportionately affected by the opioid crisis (3,4)."/>
  <result pre="the opioid crisis (3,4). However, targeted strategies for identifying HCV" exact="infection" post="among persons who inject drugs is challenging (5,6). During"/>
  <result pre="can implicitly accept or explicitly decline testing), universal hepatitis C" exact="screening" post="for all adult patients. ED staff members offered HCV"/>
  <result pre="all adult patients. ED staff members offered HCV antibody (anti-HCV)" exact="screening" post="to patients who were unaware of their status.* During"/>
  <result pre="staff members tested 14,252 patients and identified an overall 9.2%" exact="prevalence" post="of positive results for anti-HCV among the adult patient"/>
  <result pre="among the adult patient population. Among the 1945â€&quot;1965 birth cohort," exact="prevalence" post="of positive results for anti-HCV (13.9%) was significantly higher"/>
  <result pre="whites (whites) (12.2%) (p&amp;lt;0.001). Among persons born after 1965, overall" exact="prevalence" post="of positive results for anti-HCV was 6.7% and was"/>
  <result pre="prevalences and the potential for ED venues and opt-out, universal" exact="testing" post="strategies to improve HCV infection awareness and surveillance for"/>
  <result pre="ED venues and opt-out, universal testing strategies to improve HCV" exact="infection" post="awareness and surveillance for hard-to-reach populations. This opt-out, universal"/>
  <result pre="infection awareness and surveillance for hard-to-reach populations. This opt-out, universal" exact="testing" post="approach is supported by new recommendations for hepatitis C"/>
  <result pre="testing approach is supported by new recommendations for hepatitis C" exact="screening" post="at least once in a lifetime for all adults"/>
  <result pre="all adults aged â‰¥18 years, except in settings where the" exact="prevalence" post="of positive results for HCV infection is &amp;lt;0.1% (7)."/>
  <result pre="in settings where the prevalence of positive results for HCV" exact="infection" post="is &amp;lt;0.1% (7). A retrospective study from four urban"/>
  <result pre="Institutional Review Board. Each ED implemented opt-out, universal hepatitis C" exact="testing" post="at different times and using differing methodologies among patients"/>
  <result pre="results available during the ED visit, and reflex HCV RNA" exact="testing" post="performed on specimens collected during the ED encounter from"/>
  <result pre="to deliver positive test results and facilitate referral to HCV" exact="infection" post="care. ED sites collected cumulative hepatitis C testing outcomes"/>
  <result pre="to HCV infection care. ED sites collected cumulative hepatitis C" exact="testing" post="outcomes for the 4-month study period, including cumulative anti-HCV"/>
  <result pre="the University of Alabama at Birmingham site. Patient characteristics and" exact="prevalence" post="estimates for positive results for anti-HCV were reported with"/>
  <result pre="to conduct all statistical analyses. Using opt-out, universal hepatitis C" exact="screening" post="(Table 1), EDs performed a total of 14,252 tests"/>
  <result pre="had positive test results for anti-HCV (Table 2). HCV RNA" exact="testing" post="for current infection was performed for 1,118 (85%) visitors"/>
  <result pre="results for anti-HCV (Table 2). HCV RNA testing for current" exact="infection" post="was performed for 1,118 (85%) visitors with positive test"/>
  <result pre="positive HCV RNA test results, indicating current HCV infection. The" exact="prevalence" post="of positive results for anti-HCV was higher among persons"/>
  <result pre="cases reactive to anti-HCV identified. TABLE 1 Universal hepatitis C" exact="testing" post="programs at four urban emergency departments (EDs) â€&quot; Birmingham,"/>
  <result pre="15, 2016 Opt-out, nurse-driven intervention using electronic EHR prompts, physician" exact="counseling" post="for positive results for anti-HCV during ED visit, or"/>
  <result pre="for anti-HCV during ED visit, or specimens for HCV RNA" exact="testing" post="collected during visit for persons with positive results for"/>
  <result pre="2016 Opt-out, nurse-driven intervention using EHR prompts at triage, physician" exact="counseling" post="for positive results for anti-HCV during ED visit, or"/>
  <result pre="for anti-HCV during ED visit, or specimens for HCV RNA" exact="testing" post="collected during visit for persons with positive results for"/>
  <result pre="anti-HCV at callback after ED visit, or diagnostic HCV RNA" exact="testing" post="at callback after the visit for persons with positive"/>
  <result pre="for all ED patients undergoing phlebotomy, with reflex HCV RNA" exact="testing" post="for persons with positive results for anti-HCV Abbreviations: anti-HCVÂ"/>
  <result pre="HCVÂ =Â hepatitis C virus. * Limited to a 3-month" exact="testing" post="period because of programmatic changes occurring during the observation"/>
  <result pre="occurring during the observation period. TABLE 2 Universal hepatitis C" exact="testing" post="results at four urban emergency departments (EDs) â€&quot; Birmingham,"/>
  <result pre="Oakland, California; Baltimore, Maryland; and Boston, Massachusetts, 2015â€&quot;2017 Client and" exact="testing" post="characteristic Study sites and dates University of Alabama at"/>
  <result pre="18,916 18,272 13,069 26,870 77,127 Patients eligible for hepatitis C" exact="testing" post="13,999 9,585 7,639 12,284 43,507â€ Anti-HCV tests performed 5,973"/>
  <result pre="(63.3) 79 (63.2) 27 (71.1) 335 (60.1) 693 (62.0) Estimated" exact="prevalence" post="of positive results for HCV RNA (%) 4.9 3.6"/>
  <result pre="(%) 4.9 3.6 5.2 9.1 5.7 State and national estimated" exact="prevalence" post="of positive results for HCV RNA, % Alabama, 0.85"/>
  <result pre="HCVÂ =Â hepatitis C virus. * Limited to a 3-month" exact="testing" post="period because of programmatic changes occurring during the observation"/>
  <result pre="and no self-reported history of prior HCV infection. Â§ Reasons" exact="testing" post="not performed included that the patient declined testing or"/>
  <result pre="Â§ Reasons testing not performed included that the patient declined" exact="testing" post="or venipuncture was not performed because no diagnostic tests"/>
  <result pre="Among persons born during 1945â€&quot;1965, overall positive results for anti-HCV" exact="prevalence" post="was significantly higher among blacks (16.0%) than among whites"/>
  <result pre="blacks (16.0%) than among whites (12.2%) (p&amp;lt;0.001). In contrast, overall" exact="prevalence" post="of positive results for anti-HCV among persons born after"/>
  <result pre="of positive results for hepatitis C virus antibody (anti-HCV) and" exact="prevalence" post="differences, by study site and patient characteristics â€&quot; Birmingham,"/>
  <result pre="confidence interval, NHÂ =Â non-Hispanic. * Bias-corrected 95% CIs for" exact="prevalence" post="differences calculated by using 1,000 bootstrap replicates. Among persons"/>
  <result pre="Among persons born during 1945â€&quot;1965, and those born after 1965," exact="prevalence" post="of positive results for anti-HCV was significantly higher among"/>
  <result pre="and 9.0%, respectively, versus 3.0%; p&amp;lt;0.001). Discussion Opt-out, universal HCV" exact="screening" post="in four geographically diverse, urban EDs identified a high"/>
  <result pre="screening in four geographically diverse, urban EDs identified a high" exact="prevalence" post="of previously unrecognized positive results for anti-HCV in approximately"/>
  <result pre="5.7%, which was substantially higher than the estimated overall U.S." exact="prevalence" post="of positive results for HCV RNA of 0.95% (8)."/>
  <result pre="HCV RNA of 0.95% (8). At the state level, ED" exact="prevalence" post="of positive results for HCV RNA ranged from three"/>
  <result pre="RNA ranged from three to fivefold higher than the upper-estimated" exact="prevalence" post="of positive results for HCV RNA rates in each"/>
  <result pre="high yield and potential impact of an ED-based opt-out, universal" exact="testing" post="strategy. Considering that the advent of HCV curative therapies,"/>
  <result pre="advent of HCV curative therapies, potential exists to eliminate HCV" exact="infection" post="from U.S. communities. For this reason, identification of persons"/>
  <result pre="For this reason, identification of persons unaware of their HCV" exact="infection" post="has become a public health priority. Because of the"/>
  <result pre="public health priority. Because of the increasing incidence of HCV" exact="infection" post="among persons who inject drugs, testing and treatment of"/>
  <result pre="increasing incidence of HCV infection among persons who inject drugs," exact="testing" post="and treatment of this population is needed for both"/>
  <result pre="of HCV infection among persons who inject drugs, testing and" exact="treatment" post="of this population is needed for both infection prevention"/>
  <result pre="testing and treatment of this population is needed for both" exact="infection" post="prevention and for ending the HCV infection epidemic. Although"/>
  <result pre="needed for both infection prevention and for ending the HCV" exact="infection" post="epidemic. Although recent studies of ED-based, targeted hepatitis C"/>
  <result pre="infection epidemic. Although recent studies of ED-based, targeted hepatitis C" exact="testing" post="have highlighted the high prevalence of positive results for"/>
  <result pre="of ED-based, targeted hepatitis C testing have highlighted the high" exact="prevalence" post="of positive results for anti-HCV among the 1945â€&quot;1965 birth"/>
  <result pre="alone would fail to identify half of persons with HCV" exact="infection" post="(8,9). Most striking in the current study was the"/>
  <result pre="(8,9). Most striking in the current study was the high" exact="prevalence" post="of positive results for anti-HCV (6.7%) noted among the"/>
  <result pre="(6.7%) noted among the younger population, driven by the high" exact="prevalence" post="of positive results for anti-HCV among whites (15.3%). Although"/>
  <result pre="this racial/ethnic difference is consistent with the epidemiology of HCV" exact="infection" post="and injection drug use behavior (2). By leveraging lessons"/>
  <result pre="use behavior (2). By leveraging lessons learned from national HIV" exact="testing" post="efforts, opt-out, universal HCV screening might improve rates of"/>
  <result pre="lessons learned from national HIV testing efforts, opt-out, universal HCV" exact="screening" post="might improve rates of hepatitis C testing among populations"/>
  <result pre="opt-out, universal HCV screening might improve rates of hepatitis C" exact="testing" post="among populations at high risk by reducing patient and"/>
  <result pre="as a prerequisite for testing. In addition, the opt-out, universal" exact="screening" post="strategy that requires less risk behavior questioning is easier"/>
  <result pre="priorities. Although both targeted and opt-out, universal ED-based hepatitis C" exact="testing" post="strategies are effective at identifying previously unrecognized HCV infections,"/>
  <result pre="are effective at identifying previously unrecognized HCV infections, reimbursement for" exact="testing" post="and challenging HCV infection care navigation remain crucial barriers."/>
  <result pre="previously unrecognized HCV infections, reimbursement for testing and challenging HCV" exact="infection" post="care navigation remain crucial barriers. A 2014 decision from"/>
  <result pre="&amp;amp; Medicaid Services precluding EDs from reimbursement for hepatitis C" exact="testing" post="might be limiting adoption of any systematic hepatitis C"/>
  <result pre="testing might be limiting adoption of any systematic hepatitis C" exact="testing" post="in the majority of EDs.â€ In addition, the high"/>
  <result pre="EDs.â€ In addition, the high number of persons with HCV" exact="infection" post="identified in the ED setting challenges HCV navigation programs"/>
  <result pre="support to effectively direct persons who test positive to HCV" exact="treatment" post="and other necessary health services, including primary care, social"/>
  <result pre="to at least three limitations. First, identifying previously unrecognized HCV" exact="infection" post="is limited by the patientâ€™s recall of their prior"/>
  <result pre="is limited by the patientâ€™s recall of their prior HCV" exact="infection" post="history and is therefore subject to bias. Second, 29,255"/>
  <result pre="Second, 29,255 persons identified as being eligible for hepatitis C" exact="testing" post="in the study EDs were not tested because a"/>
  <result pre="consistent with previously reported findings from ED-based targeted hepatitis C" exact="testing" post="(5,6), and bias was not introduced toward testing persons"/>
  <result pre="hepatitis C testing (5,6), and bias was not introduced toward" exact="testing" post="persons appearing to be at high risk. Finally, study"/>
  <result pre="geographic areas or in nonurban or community EDs. The high" exact="prevalence" post="of HCV infection identified among persons born after 1965"/>
  <result pre="in nonurban or community EDs. The high prevalence of HCV" exact="infection" post="identified among persons born after 1965 as well as"/>
  <result pre="ED-based hepatitis C testing, as well as an opt-out, universal" exact="screening" post="strategy among similar high-prevalence health care venues. Given the"/>
  <result pre="strategy among similar high-prevalence health care venues. Given the high" exact="prevalence" post="of positive results for HCV RNA identified among a"/>
  <result pre="disproportionately affected by the opioid crisis, ED-based opt-out, universal HCV" exact="screening" post="might play an important role in surveillance and combat"/>
  <result pre="treatment. Summary What is already known about this topic? Targeted" exact="testing" post="for hepatitis C virus (HCV) infection in emergency departments"/>
  <result pre="about this topic? Targeted testing for hepatitis C virus (HCV)" exact="infection" post="in emergency departments (EDs) has been demonstrated to be"/>
  <result pre="1945â€&quot;1965. What is added by this report? Opt-out, universal HCV" exact="screening" post="in EDs identified that nearly half (47.5%) of infections"/>
  <result pre="What are the implications for public health practice? Opt-out, universal" exact="screening" post="in EDs can identify a larger number of previously"/>
  <result pre="among persons born after 1965. ED-based opt-out, universal hepatitis C" exact="screening" post="can be vital in combating and surveilling the interrelated"/>
  <result pre="interventions and navigation to HCV treatment. *To reduce potential duplicate" exact="testing" post="of patients, sites utilized electronic health record mechanisms to"/>
  <result pre="cancel HCV antibody orders on persons with prior HCV antibody" exact="testing" post="in the last year, as well as any prior"/>
  <result pre="al.. Recommendations for the identification of chronic hepatitis C virus" exact="infection" post="among persons born during 1945â€&quot;1965.MMWR Recomm Rep2012;61(No. RR-4).22895429 2."/>
  <result pre="5. GalbraithJW, FrancoRA, DonnellyJP, et al.Unrecognized chronic hepatitis C virus" exact="infection" post="among baby boomers in the emergency department.Hepatology2015;61:776â€&quot;82. 10.1002/hep.2741025179527 6."/>
  <result pre="PfeilSK, TrivediTK, AlterHJ. Results of a rapid hepatitis C virus" exact="screening" post="and diagnostic testing program in an urban emergency department.Ann"/>
  <result pre="Results of a rapid hepatitis C virus screening and diagnostic" exact="testing" post="program in an urban emergency department.Ann Emerg Med2016;67:119â€&quot;28. 10.1016/j.annemergmed.2015.06.02326253712"/>
  <result pre="SchillieS, WesterC, OsborneM, WesolowskiL, RyersonAB. CDC recommendations for hepatitis C" exact="screening" post="among adultsâ€&quot;United States, 2020.MMWR Recomm Rep2020;69(No. RR-2). 10.15585/mmwr.rr6902a132271723 8."/>
  <result pre="8. RosenbergES, RosenthalEM, HallEW, et al.Prevalence of hepatitis C virus" exact="infection" post="in US states and the District of Columbia, 2013"/>
  <result pre="for Disease Control and Prevention recommendations for hepatitis C virus" exact="testing" post="in an urban emergency department.Clin Infect Dis2016;62:1059â€&quot;65. 10.1093/cid/ciw07426908800"/>
 </snippets>
</snippetsTree>
